Supplementary Tables – Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis

Supplementary Table 1. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis The data available status for subgroup-analyses among the included trials. Supplementary Table 2. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis Sensitivity analysis after removing the trials using the third-generation EGFR TKI. Supplementary Table 3. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis Sensitivity analysis after removing the trials unselecting EGFR mutation status. Supplementary Table 4. Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated NSCLC：A meta-analysis Sensitivity analysis using both fixed-effects and random-effects models.